Breaking AI & Tech News Analyzed

Jurors in two separate U.S. courts delivered historic rulings that, for the first time, hold major social‑media platforms financially accountable for designs that allegedly harm young users. In New Mexico, a jury ordered Meta to pay $375 million for claims that its products contributed to child sexual exploitation and other harms. The following day, a California jury found both Meta and YouTube liable, imposing $6 million in damages for deliberately engineering addictive experiences. The verdicts arrive amid a wave of lawsuits filed by more than 2,000 plaintiffs—including families, school districts, and state attorneys general—targeting Meta, YouTube, TikTok and Snap. While both companies have announced intentions to appeal, the judgments signal a shift from public criticism to concrete legal exposure. During the trials, Meta’s defense repeatedly cited the American Psychiatric Association’s position that “social media addiction is not a thing” in the DSM‑5‑TR. The APA countered that the absence of a formal diagnosis does not negate the phenomenon’s existence, emphasizing growing research on the mental‑health impacts of compulsive platform use. Internal communications presented as evidence painted a starkly different picture. A 2020 Meta email exchange described Instagram as “a drug” and likened the company’s role to that of “pushers,” while another message warned that targeting 11‑year‑olds resembled tactics once used by tobacco firms. Similar concerns emerged from YouTube, where an internal document explicitly stated the goal was “not viewership, it’s viewer addiction.” TikTok’s own research echoed these findings, concluding that users could become addicted in under 35 minutes and that compulsive usage correlates with a range of negative mental‑health outcomes. Moody’s, a risk‑assessment firm, warned that the dual verdicts establish a precedent whereby design‑driven user harm can trigger liability. In an analysis, analysts Adam Grossman and Taro Ramberg noted that insurers should focus on the emerging “design‑centered liability theory,” which links engagement‑driven features—such as infinite scrolling and autoplay—to compensable injuries. They cautioned that the current cases are merely the first data points in a broader legal trend. Beyond social media, the same design principles appear in video games, sports‑betting platforms, AI chatbots and online retail. Moody’s tracker lists over 1,100 pending cases in Los Angeles alone and estimates roughly 4,000 lawsuits targeting 166 U.S. companies for allegedly addictive software design. Both Meta and YouTube maintain that they disagree with the verdicts. YouTube’s spokesperson called the California decision a “misunderstanding” of the platform’s nature, while Meta emphasized the complexity of teen mental health and the non‑unanimous nature of the California jury’s finding. Nevertheless, the courts have signaled that even without a settled clinical definition of “social‑media addiction,” companies can be held responsible for the foreseeable harms of their product designs.

Robert F Kennedy Jr, the US health secretary, has unveiled a chaotic and unpredictable agenda for public health policy under his 'Make America Healthy Again' (Maha) initiative. His approach tends to favor personal choice and autonomy over large-scale, mandatory public health interventions, such as childhood vaccine requirements.The Maha agenda has raised concerns over the potential risks associated with injectable peptide drugs. Mr. Kennedy plans to open up the sale of 'about 14' of these drugs to the public, despite the US Food and Drug Administration (FDA) restricting 17 peptides in 2023 due to 'potential significant safety risks'. None of these peptides have been proven to be safe or effective for human use.The peptides in question are often promoted for biological enhancement, such as increasing muscle mass or cognitive benefits, but the evidence for these effects in humans is thin. Reports of people self-administering peptide therapies, usually bought from China 'for research use only', are widespread, particularly in Silicon Valley.The Maha project wants to make the grey market the only market, effectively sanctioning mass public use of unproven treatments. Peptides are clearly drugs and shouldn’t be allowed for widespread use without rigorous clinical trials. Opening loopholes for sale would undermine the precautionary principle that has successfully led public health policy for generations.It is also worth noting that other governments are unlikely to be as cavalier as Mr. Kennedy about peptides. However, people everywhere will continue to call for more personal choice and more bodily autonomy, and those conversations are important. The case for safety, proof, and regulation must be made to ensure that public health policy prioritizes the well-being of individuals.

Manchester City delivered a resounding statement of intent in their latest Women's Super League fixture, dismantling Manchester United 3-0 at Old Trafford in a derby that showcased the vast gulf between the two teams. The victory propelled City closer to securing their first league title in a decade, while simultaneously damaging United's hopes of European qualification next season.Vivianne Miedema was the star of the show, scoring twice with headers in the first half, while Kerstin Casparij added a third goal early in the second period. Lauren Hemp also hit the crossbar as City dominated throughout, with the home side fortunate not to concede more goals in a match that highlighted the disparity between the teams.Manchester United head coach Marc Skinner attributed his team's performance to fatigue following their Champions League encounter with Bayern Munich three days prior. In contrast, City has benefited from not competing in European competitions this season, allowing for crucial rest between matches. Skinner acknowledged the advantage enjoyed by City manager Andrée Jeglertz, who described his team's first-half display as "one of the best we've done this season."The result has effectively ended United's title ambitions, with Skinner's side now trailing by 11 points with only three games remaining. Chelsea's hopes of retaining their crown have also been extinguished, as they sit 12 points behind with an inferior goal difference. Arsenal remains the only mathematical challenger, though they would need City to falter significantly in their remaining fixtures.City's dominance was evident from the opening minutes, with Miedema opening the scoring from a corner just 21 seconds into the match. She doubled her tally before the break, finding herself unmarked in the penalty area as United's defense failed to deal with a cross from Casparij. Hemp struck the woodwork before a Rebecca Knaak goal was controversially disallowed, and Casparij sealed the victory with a clinical finish after the interval.With City now requiring just five points from their remaining three matches—all against bottom-four teams—the WSL title appears destined to return to the Etihad Stadium. Meanwhile, United faces an uphill battle to secure European qualification, with challenging fixtures against Tottenham and Chelsea still to come this season.

Tom Pidcock, a two-time Olympic cross-country mountain bike champion, has been withdrawn from the Volta a Catalunya due to injuries sustained in a dramatic crash during the fifth stage on Friday. The British rider, competing for Pinarello-Q36.5, misjudged a corner on a descent and tumbled down a ravine in what he described as a 'horror' crash.Despite managing to get back on his bike and complete the stage, medical assessments revealed significant injuries, including likely bone and ligament damage to his right knee and wrist. As a result, it was decided that Pidcock could not continue the race.“Due to his crash he suffered injuries, most likely bone and ligament damage in particular to his right knee and also right wrist,” said Lorenz Emmert, Pinarello-Q36.5’s chief medical team doctor. “Unfortunately we had to make the decision to take him out of the race. Further clinical evaluation and imaging will follow in the next days additionally to the already-initiated healing process.”Pidcock reflected on the incident, stating: “I was drinking on the descent and misjudged a corner. I overshot it and went down the ravine. It was like one of these horror crashes you see, but I’m very lucky that I am OK.” He added that he will focus on recovery and aims to return to competition soon.

Scientists have made a groundbreaking discovery that could lead to the development of new obesity drugs. By studying the unique metabolic abilities of pythons, researchers have identified a molecule that appears to play a crucial role in regulating appetite and weight loss. The molecule, called pTOS, was found to increase significantly in the blood of pythons after they eat, and when administered to obese mice, it led to a significant reduction in food intake and a 9% loss of body weight over 28 days. The discovery could lead to the development of new obesity drugs that work in a different way to existing medications, such as GLP-1 medications like Wegovy. Unlike these medications, which can have side effects such as nausea and stomach pain, pTOS appears to act on the brain's appetite centers, reducing food intake without these adverse effects. The researchers, led by Dr. Jonathan Long from Stanford University and Prof. Leslie Leinwand from the University of Colorado Boulder, published their findings in the journal Nature Metabolism. They believe that pTOS, which is naturally produced by the snake's gut bacteria and also found in human urine, could be a safe and effective treatment for obesity. While further research is needed before the findings can be applied clinically, the discovery is seen as a promising step towards the development of new obesity treatments. The study's results suggest that pTOS could be a potential therapeutic target for the treatment of obesity and related metabolic disorders.

Lemi Limbu, a woman with severe intellectual disabilities in Tanzania, has had her conviction and death sentence quashed after spending more than a decade in prison awaiting execution. Limbu, now in her early 30s, was convicted of the murder of her daughter in 2015.On 4 March, a court in Shinyanga, northern Tanzania, declared she can appeal. She will face a retrial, but a date has yet to be set. Lawyers and activists have condemned her sentence, saying she should not be in prison at all. Limbu, who remains incarcerated, is a survivor of brutal and repeated sexual and domestic violence and has the developmental age of a child.Under Tanzanian and international law, Limbu should not be held criminally liable, given her intellectual disability. “She was not supposed to be in prison in the first place,” said Anna Henga, executive director of Legal and Human Rights Centre, a Tanzanian human rights advocacy organisation.At her first trial, Limbu pleaded not guilty. Unable to read or write, she said she did not know the contents of a statement that police claimed she had made admitting to the murder. Her original conviction in 2015 was nullified in 2019 due to procedural errors. In 2022, she was retried and sentenced to death a second time.The court did not allow evidence to be heard from medical professionals about her intellectual disabilities or history of abuse. A clinical psychologist who evaluated her had concluded she had a severe intellectual disability and the developmental age of a 10-year-old child or younger.A coalition of 24 African and international human rights groups last year condemned Limbu’s sentence as part of an appeal to the African court on human and peoples’ rights to look at the plight of women on death row throughout Africa. In Tanzania, the death penalty is the mandatory sentence for murder, although no executions have been carried out since 1995.